Lockheed Martin Investment Management CO Dexcom Inc Transaction History

Lockheed Martin Investment Management CO

  • $2.15 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 14, 2018
SELL
$17.54 - $25.22 $136,461 - $196,211
-7,780 Closed
0 $0
Q4 2017

Jan 18, 2018
SELL
$11.12 - $15.38 $1,334 - $1,845
-120 Reduced 1.52%
7,780 $446,000
Q3 2017

Nov 06, 2017
BUY
$11.36 - $18.98 $89,744 - $149,942
7,900
7,900 $387,000

Others Institutions Holding DXCM

# of Institutions
1,014
Shares Held
351M
Call Options Held
5.51M
Put Options Held
5.6M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $28.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Lockheed Martin Investment Management CO Portfolio

Follow Lockheed Martin Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lockheed Martin Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Lockheed Martin Investment Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email